COURT-RULING filed Sep 9, 2026 at 20:00 ET
The court granted Brandeis University leave to file a Second Amended Complaint against Bio-Rad, allowing new allegations that Bio-Rad failed to notify Brandeis about Quanterix's infringement of licensed patents for ~7.5 years, potentially depriving Brandeis of ~1.5 years of patent damages. Bio-Rad's motion to dismiss was denied as moot. This is an early-stage procedural ruling (motion for leave to amend) that keeps the case alive but does not resolve any liability or damages, a modest negative for Bio-Rad as litigation risk persists, but the financial exposure remains unquantified and the ruling is not a merits determination.